ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,600Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 2456

$639K Total Retail Price of All Prescriptions

Rank: 136 out of 2456

460 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 561 405 1 9
SIMVASTATIN 520 397 2 2
LISINOPRIL 463 382 3 1
OMEPRAZOLE 319 242 4 3
ATENOLOL 297 240 5 6
FUROSEMIDE 290 237 6 8
METOPROLOL SUCCINATE 282 255 7 13
CITALOPRAM HBR 267 228 8 14
HYDROCHLOROTHIAZIDE 254 200 9 7
TRAZODONE HCL 242 168 10 17
LEVOTHYROXINE SODIUM 241 181 11 4
SERTRALINE HCL 208 136 12 21
AMLODIPINE BESYLATE 206 177 13 5
GABAPENTIN 186 107 14 16
METFORMIN HCL 175 135 15 11
TRAMADOL HCL 158 65 16 24
METOPROLOL TARTRATE 156 122 17 10
PRAVASTATIN SODIUM 145 102 18 15
OXYCODONE-ACETAMINOPHEN 129 78 S2 19 35
BACLOFEN 116 14 20 112
ALENDRONATE SODIUM 111 54 21 19
PROAIR HFA 111 62 21 22
OLANZAPINE 110 88 23 57
DONEPEZIL HCL 105 95 24 23
RANITIDINE HCL 103 52 25 31
MIRTAZAPINE 103 93 25 29
HYDROCODONE-ACETAMINOPHEN 101 53 S3 27 20
FLUOXETINE HCL 99 36 28 45
ATORVASTATIN CALCIUM 96 86 29 12
IBUPROFEN 94 41 30 52
OXYBUTYNIN CHLORIDE ER 91 46 31 94
ALLOPURINOL 90 48 32 27
TAMSULOSIN HCL 87 87 33 32
POTASSIUM CHLORIDE 86 56 34 33
PAROXETINE HCL 81 48 35 56
GLYBURIDE 81 63 R 35 40
LIDODERM 81 67 35 58
NORTRIPTYLINE HCL 79 56 38 227
SPIRIVA 76 60 39 43
NYSTOP 72 37 40 125
FLUTICASONE PROPIONATE 72 51 40 30
ADVAIR DISKUS 69 53 42 36
LOVASTATIN 66 54 43 34
GLIPIZIDE 63 50 44 46
CYCLOBENZAPRINE HCL 60 15 R 45 77
LEVETIRACETAM 58 35 46 90
CARVEDILOL 57 45 47 54
OXYBUTYNIN CHLORIDE 57 18 47 152
LOSARTAN POTASSIUM 54 54 49 18
SANTYL 53 31 50 323
PANTOPRAZOLE SODIUM 53 49 50 37
GENERLAC 53 28 50 142
DOXAZOSIN MESYLATE 52 43 53 71
LANTUS 51 42 54 44
QUETIAPINE FUMARATE 51 20 54 47
LEVOFLOXACIN 50 27 56 103
CYMBALTA 50 49 56 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.